Colorectal Cancer Screening Guidelines
Colorectal cancer screening should begin at age 45 for average-risk individuals, continue through age 75, and include colonoscopy every 10 years or annual FIT as first-tier screening options. 1, 2
Screening Age Recommendations
When to Start Screening:
- Average-risk individuals: 45 years 1, 3
- African Americans: 45 years (some guidelines recommend 40 years) 3, 1
- Family history of CRC or advanced adenoma:
When to Stop Screening:
- Ages 76-75: Continue screening for those in good health with life expectancy >10 years 1, 2
- Ages 76-85: Individualize decision based on prior screening history, health status, and life expectancy 1
- After age 85: Discontinue screening 1
Recommended Screening Modalities
Tier 1 (Preferred Options):
- Colonoscopy every 10 years
- Fecal Immunochemical Test (FIT) annually
Tier 2 Options:
- CT colonography every 5 years
- FIT-fecal DNA (Cologuard) every 3 years
- Flexible sigmoidoscopy every 5-10 years
Tier 3 Option:
- Capsule colonoscopy every 5 years (limited evidence)
Screening Test Performance
| Test | Sensitivity for CRC | Sensitivity for Advanced Precancerous Lesions | Specificity |
|---|---|---|---|
| Cologuard | 92.3% | 42.4% | 86.6% |
| FIT | 73.8% | 23.8% | 94.9% |
Risk-Based Screening Recommendations
High-Risk Individuals:
Inflammatory bowel disease (ulcerative colitis or Crohn's with colonic involvement):
- Begin 8-10 years after symptom onset
- Repeat every 1-3 years 4
Hereditary nonpolyposis colorectal cancer (HNPCC/Lynch syndrome):
- Begin at age 25
- Repeat every 1-2 years 4
Adenomatous polyposis syndromes:
- Begin at age 10 or mid-20s depending on syndrome
- Repeat every 1-2 years 4
Peutz-Jeghers syndrome:
- Begin at age 8
- If normal, repeat at age 18, then every 3 years 4
Follow-Up Recommendations
- Positive stool-based test: Follow up with diagnostic colonoscopy 1
- Adenomatous polyps removed: Follow up with colonoscopy in 3-5 years (depending on size and number) 1
- Normal colonoscopy: Repeat in 10 years for average-risk individuals 1
Clinical Considerations
Test Selection:
- Colonoscopy is most appropriate for individuals with multiple risk factors 1
- Patient preferences should be considered to improve adherence 1
- Digital rectal exam alone is insufficient for screening 1
- Air-contrast barium enema is no longer recommended as a primary screening tool 1
Potential Harms:
- Colonoscopy: Small risk of perforation and bleeding
- CT colonography: Radiation exposure
- Stool-based tests: False positives leading to unnecessary follow-up procedures 1
Common Pitfalls to Avoid
Delaying screening: The rising incidence of CRC in persons under 50 necessitates thorough evaluation of young persons with suspected colorectal bleeding 2
Missing proximal lesions: Flexible sigmoidoscopy alone would miss up to 38% of polyps in the absence of distal findings 5
Inadequate follow-up: Failing to follow up positive stool-based tests with timely colonoscopy 1
Overscreening: Continuing screening beyond age 75 in individuals with prior negative screening and limited life expectancy 2
Underscreening high-risk groups: African Americans have the highest incidence and mortality rates for CRC compared to other racial/ethnic groups (43.6 vs 37.8 cases per 100,000 in White adults) 1